Umeworld SEC Filings

UMeWorld Inc. director Keith Ford Moore filed an initial ownership report showing he directly holds 3,142,214 shares of the company’s Common Stock. This Form 3 reflects his existing position as a director and does not report any new purchases or sales.

UMeWorld Inc. reported a sharp ramp-up in sales but remains deeply unprofitable and financially strained. Revenue for the three months ended March 31, 2026 rose to $351,187 from $411 a year earlier, driven mainly by distributor sales in China. For the six-month period, revenue reached $498,642.

Despite this, gross profit was modest at $15,152 for the quarter and $19,694 year-to-date, while operating expenses climbed, producing a quarterly net loss of $105,450 and a six‑month net loss of $244,177. Cash was $145,445 and total assets $1.52 million, against liabilities of $1.74 million and a stockholders’ deficit of $214,260, with a disclosed working capital deficiency of similar magnitude.

Management states there is substantial doubt about the company’s ability to continue as a going concern and plans to pursue growth in functional nutrition markets and additional financing. The business has heavy concentration risks, with about 99.17% of six‑month revenue from China and roughly 88.94% from a single distributor, and relies on a specialized DAG oil supplier. During the quarter, UMeWorld issued 814,588 shares to convert $203,647 of related‑party advances and sold 500,000 shares for $150,000 of cash. Disclosure controls and procedures were deemed not effective due to limited accounting personnel and segregation of duties, and remediation efforts are underway.

UMeWorld Inc. reported a sharp ramp-up in sales but remains deeply unprofitable and financially strained. Revenue for the three months ended March 31, 2026 rose to $351,187 from $411 a year earlier, driven mainly by distributor sales in China. For the six-month period, revenue reached $498,642.

Despite this, gross profit was modest at $15,152 for the quarter and $19,694 year-to-date, while operating expenses climbed, producing a quarterly net loss of $105,450 and a six‑month net loss of $244,177. Cash was $145,445 and total assets $1.52 million, against liabilities of $1.74 million and a stockholders’ deficit of $214,260, with a disclosed working capital deficiency of similar magnitude.

Management states there is substantial doubt about the company’s ability to continue as a going concern and plans to pursue growth in functional nutrition markets and additional financing. The business has heavy concentration risks, with about 99.17% of six‑month revenue from China and roughly 88.94% from a single distributor, and relies on a specialized DAG oil supplier. During the quarter, UMeWorld issued 814,588 shares to convert $203,647 of related‑party advances and sold 500,000 shares for $150,000 of cash. Disclosure controls and procedures were deemed not effective due to limited accounting personnel and segregation of duties, and remediation efforts are underway.

UMeWorld Inc. filed an initial ownership report showing that its CFO, Ding Yongbiao, holds 1,663,834 common shares directly following the reported date. This Form 3 filing establishes his baseline ownership position as an officer of the company.

UMeWorld Inc. filed an initial ownership report showing that its CFO, Ding Yongbiao, holds 1,663,834 common shares directly following the reported date. This Form 3 filing establishes his baseline ownership position as an officer of the company.

UMeWorld Inc. director Milroy John David filed an initial statement of ownership on Form 3. He reports direct beneficial ownership of 1,342,131 shares of common stock and indirect beneficial ownership of 38,000 shares held by his spouse, all as of January 21, 2026.

UMeWorld Inc. director Milroy John David filed an initial statement of ownership on Form 3. He reports direct beneficial ownership of 1,342,131 shares of common stock and indirect beneficial ownership of 38,000 shares held by his spouse, all as of January 21, 2026.

UMeWorld Inc. reported a sharp jump in quarterly revenue but remains deeply unprofitable and financially strained. For the three months ended December 31, 2025, revenue rose to $147,455 from $195 a year earlier, driven mainly by an initial distributor order in China.

The company still posted a net loss of $138,727 and ended the quarter with cash of $60,904, a working capital deficiency of about $462,599, and an accumulated deficit of $32,068,371, leading auditors to highlight substantial doubt about its ability to continue as a going concern.

Inventory ballooned to $1,682,509 from $13,410, while accounts payable increased to $1,670,243, reflecting heavy stocking and reliance on vendor credit. The business depends on a single Chinese supplier for specialized DAG oil and a key distributor that accounted for about 98% of quarterly revenue. Management is seeking additional capital and expanding distribution but also disclosed that disclosure controls and procedures were not effective due to internal control weaknesses.

UMeWorld Inc. reported a sharp jump in quarterly revenue but remains deeply unprofitable and financially strained. For the three months ended December 31, 2025, revenue rose to $147,455 from $195 a year earlier, driven mainly by an initial distributor order in China.

The company still posted a net loss of $138,727 and ended the quarter with cash of $60,904, a working capital deficiency of about $462,599, and an accumulated deficit of $32,068,371, leading auditors to highlight substantial doubt about its ability to continue as a going concern.

Inventory ballooned to $1,682,509 from $13,410, while accounts payable increased to $1,670,243, reflecting heavy stocking and reliance on vendor credit. The business depends on a single Chinese supplier for specialized DAG oil and a key distributor that accounted for about 98% of quarterly revenue. Management is seeking additional capital and expanding distribution but also disclosed that disclosure controls and procedures were not effective due to internal control weaknesses.

UMeWorld Inc. Chairman and CEO Lee Man Ching has filed an initial insider ownership report, disclosing direct holdings of 7,242,291 shares of UMeWorld common stock. This Form 3 filing records his existing ownership position and, based on the data shown, does not reflect new buying or selling activity.

UMeWorld Inc. Chairman and CEO Lee Man Ching has filed an initial insider ownership report, disclosing direct holdings of 7,242,291 shares of UMeWorld common stock. This Form 3 filing records his existing ownership position and, based on the data shown, does not reflect new buying or selling activity.

UMeWorld Inc. filed a notice that it will not submit its Quarterly Report on Form 10‑Q for the quarter ended December 31, 2025 on time. The delay stems from the resignation of its former independent auditor on December 31, 2025 due to that firm’s internal partner‑rotation policy and related PCAOB compliance concerns, and the company has not yet engaged a successor firm to review the interim financial statements.

The company also recently redomiciled from the British Virgin Islands to Delaware, with a related name change and shift to U.S. domestic issuer reporting, which has strained internal accounting and administrative resources. UMeWorld expects to file the 10‑Q within the five‑calendar‑day extension allowed under Rule 12b‑25. For the quarter, it anticipates a significant increase in total revenue versus the prior‑year period, driven by commercial scaling of its DAGola™ functional nutrition platform and international expansion, but it cannot yet reasonably estimate net income, earnings per share, or other specific financial results.

UMeWorld Inc. reported that, effective January 21, 2026, FINRA completed its corporate action for the company. The common stock now trades on the OTC Markets under the new symbol "UMEW" with a new CUSIP number 90292A105, and the prior CUSIP has been suspended for market purposes.

The company also completed its redomiciliation from the British Virgin Islands to the State of Delaware and formally changed its corporate name from UMeWorld Limited to UMeWorld Inc. These steps follow a previously completed share exchange and domestication process and reflect FINRA’s successor-issuer recognition. A press release announcing the effectiveness of this corporate action was issued on January 21, 2026.

UMeWorld Inc. reported that its independent registered public accounting firm, J&S Associate PLT, resigned effective December 31, 2025. The firm stepped down due to required audit engagement partner rotation under PCAOB independence rules and Regulation S‑X, rather than any issue with the company.

The auditor’s reports on UMeWorld’s financial statements for the years ended September 30, 2024 and September 30, 2025 contained no adverse opinions, disclaimers, or qualifications. The company states there were no disagreements or reportable events with the auditor during these periods. UMeWorld has asked the former auditor to provide a confirming letter to the SEC, which is included as Exhibit 16.1.

UMeWorld Inc. (UMEWF) reports very early-stage operations with persistent losses and going‑concern risk. For the year ended September 30, 2025, revenue was only $2,222, compared with $941 in 2024, generated mainly from online sales of DAGola™ functional cooking oil. Net loss widened to $258,176, driven by higher product costs and a one‑time $29,493 inventory write‑off from discontinuing the Cellugizer line.

Total assets were $170,409 and total liabilities $494,320, resulting in a stockholders’ deficit of $323,911 and a working‑capital deficiency of similar magnitude as of September 30, 2025. The auditor highlighted substantial doubt about the company’s ability to continue as a going concern, and management states it must raise additional capital to fund operations and Asia‑Pacific expansion.

The company completed a redomiciliation from the British Virgin Islands to Delaware on October 2, 2025 and now operates primarily through Dagola Inc. in Miami, selling DAGola® oils, while its biofuel initiative, Project Verdant, remains at an early, non‑revenue planning stage. UMeWorld has identified material weaknesses in internal control, is traded as a penny stock on the OTC market, has only one full‑time employee, and relies heavily on a few major shareholders and related‑party financing.